NEW YORK (GenomeWeb News) — Galapagos’ BioFocus DPI division today said it has received an extension of its certification from the International Standards Organization for its target discovery operations in its Leiden, the Netherlands.
 
BioFocus, which specializes in adenoviral agents and compound libraries for drug development, said the certification covers the chemical and biological research services it offers to pharma, biotech and agrochem businesses.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.